1. Home
  2. EVTC vs IMCR Comparison

EVTC vs IMCR Comparison

Compare EVTC & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evertec Inc.

EVTC

Evertec Inc.

HOLD

Current Price

$27.82

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$32.18

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTC
IMCR
Founded
1988
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
2013
2016

Fundamental Metrics

Financial Performance
Metric
EVTC
IMCR
Price
$27.82
$32.18
Analyst Decision
Hold
Buy
Analyst Count
5
10
Target Price
$35.80
$66.33
AVG Volume (30 Days)
339.7K
309.5K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
0.67%
N/A
EPS Growth
27.17
30.39
EPS
0.47
0.23
Revenue
$453,869,000.00
$249,428,000.00
Revenue This Year
$12.68
$14.57
Revenue Next Year
$6.86
$8.21
P/E Ratio
$58.67
$138.89
Revenue Growth
11.48
43.05
52 Week Low
$21.81
$27.56
52 Week High
$34.77
$40.71

Technical Indicators

Market Signals
Indicator
EVTC
IMCR
Relative Strength Index (RSI) 38.66 35.99
Support Level $27.64 $31.90
Resistance Level $30.40 $33.55
Average True Range (ATR) 0.92 1.16
MACD -0.21 -0.48
Stochastic Oscillator 12.57 14.45

Price Performance

Historical Comparison
EVTC
IMCR

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions. Latin America Payments and Solutions segment derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: